Medicine and Dentistry
Hepatocellular Carcinoma
100%
Neoplasm
61%
T Cell
46%
Cholangiocarcinoma
32%
Liver Transplantation
30%
Stereotactic Body Radiation Therapy
27%
Liver Cancer
27%
Radioembolization
25%
Recurrent Disease
16%
Tumor Microenvironment
15%
Overall Survival
15%
Malignant Neoplasm
14%
Ex Vivo
14%
Organoid
13%
Cancer Testis Antigen
13%
Tumor Immune Microenvironment
13%
Holmium
13%
Immunosuppressive Treatment
12%
Cytotoxic T-Cell
11%
Liver Tumor
11%
CD8 Antigen
10%
Receptor
9%
Radiation Therapy
9%
Cancer Cell
8%
Cancer Immunotherapy
8%
Cytotoxicity
8%
Liver Metastasis
8%
Colorectal Carcinoma
8%
Recurrence Risk
8%
Quality of Life
8%
Transcatheter Arterial Chemoembolization
8%
Decompensated Liver Cirrhosis
8%
Regulatory T Cell
7%
DNA Mismatch Repair
6%
Cancer Associated Fibroblast
6%
Whole Body Radiation
6%
CTLA-4
6%
Pancreas Cancer
6%
Doppler Flowmetry
6%
Therapy Resistance
6%
Thymocyte Antibody
6%
Circulating Tumor DNA
6%
HLA Matching
6%
Circulating Tumor Cell
6%
Chronic Graft Rejection
6%
Antibody Mediated Rejection
6%
Colorectal Liver Metastasis
6%
Humoral Immunity
6%
Carcinogenesis
6%
Abdominal Bleeding
6%
Immunology and Microbiology
T Cell
82%
Regulatory T Cell
30%
Immunosuppression
27%
CD8
23%
Liver Transplantation
23%
Cancer Immunotherapy
18%
CD4
18%
Tumor-Infiltrating Lymphocytes
17%
Natural Killer Cell
17%
Cytotoxic T-Cell
15%
Programmed Death-Ligand 1
14%
Cancer Testis Antigen
13%
T-Helper Cell
12%
Interleukin 10
10%
Immunotherapy
10%
Immunosuppressive Drug
10%
Cytotoxicity
10%
T Cell Subset
10%
Cell Function
9%
Tumor Necrosis Factor Receptor
9%
Cytokine
8%
LAG3
7%
Mismatch Repair
7%
Glucocorticoid
7%
Humoral Immunity
6%
Pegylated Interferon
6%
CTLA-4
6%
Sorafenib
6%
Organoid
6%
Vein Blood Flow
6%
CD4 CD8 Ratio
6%
HLA Matching
6%
Anti-Thymocyte Globulin
6%
Hepatitis B
6%
Chronic Graft Rejection
6%
Hepatic Portal Vein
6%
Arm
6%
Antibody Mediated Rejection
6%
Hepatic Artery
6%
Plasmacytoid Dendritic Cell
6%
Human Leukocyte Antigen
6%
T Helper Cell
6%
Lymphocyte
5%
Preclinical Study
5%
Overall Survival
5%
Immunosuppressant
5%
Biochemistry, Genetics and Molecular Biology
T Cell
41%
Immune Checkpoints
31%
CD8
15%
Immune Microenvironment
13%
TIGIT
13%
Cancer Staging
13%
Regulatory T Cell
8%
CD4
8%
Cytotoxicity
7%
Coculture
7%
Sorafenib
7%
Carcinogenesis
6%
Vein Blood Flow
6%
Circulating Tumor DNA
6%
Fibroblast
6%
Interferon
6%
Messenger RNA
6%
Cancer Registry
6%
Interleukin 6
6%
Molecular Genetics
6%
Humoral Immunity
6%
Interleukin 10
6%
Tumor-Infiltrating Lymphocytes
6%
PNPLA3
6%
Phlebothrombosis
6%
Immunocompetent Cell
6%
Survival Rate
6%
Hepatitis B Virus
5%
